{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:47:01Z","timestamp":1759837621445,"version":"3.41.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["N01DA-12-8904","N01DA-17-8932"],"award-info":[{"award-number":["N01DA-12-8904","N01DA-17-8932"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["N01DA-14-8917"],"award-info":[{"award-number":["N01DA-14-8917"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009238","name":"Virginia Commonwealth University","doi-asserted-by":"publisher","award":["PHTX292321"],"award-info":[{"award-number":["PHTX292321"]}],"id":[{"id":"10.13039\/100009238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.drugalcdep.2018.02.035","type":"journal-article","created":{"date-parts":[[2018,4,15]],"date-time":"2018-04-15T14:06:39Z","timestamp":1523801199000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nociceptin\/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL\/6 mice"],"prefix":"10.1016","volume":"187","author":[{"given":"D. Matthew","family":"Walentiny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Wiebelhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Beardsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0005","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1360-0443.1991.tb01747.x","article-title":"Drug abuse potential evaluation in animals","volume":"86","author":"Balster","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-004-2035-z","article-title":"Attenuation of nicotine\u2019s discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A\/2C receptor agonists","volume":"179","author":"Batman","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1037\/1064-1297.12.3.163","article-title":"Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice rats, and rhesus monkeys","volume":"12","author":"Beardsley","year":"2004","journal-title":"Exp. Clin. Psychopharmacol."},{"year":"1967","series-title":"Statistics in Biology","author":"Bliss","key":"10.1016\/j.drugalcdep.2018.02.035_bib0020"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2016_9","article-title":"Discriminative stimulus properties of opioid ligands: progress and future directions","author":"Butelman","year":"2016","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pnpbp.2013.10.016","article-title":"Dynorphin\/KOP and nociceptin\/NOP gene expression and epigenetic changes by cocaine in rat striatum and nucleus accumbens","volume":"49","author":"Caputi","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"year":"2016","series-title":"Wide-ranging Online Data for Epidemiologic Research (WONDER)","author":"Centers for Disease Control and Prevention (CDC)","key":"10.1016\/j.drugalcdep.2018.02.035_bib0035"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2016.11.026","article-title":"Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N\/OFQ(1-13)","volume":"794","author":"Cerlesi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0196-9781(00)00245-X","article-title":"Nociceptin\/orphanin FQ and drugs of abuse","volume":"21","author":"Ciccocioppo","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(00)00590-2","article-title":"Effect of nociceptin\/orphanin FQ on the rewarding properties of morphine","volume":"404","author":"Ciccocioppo","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-003-1645-1","article-title":"Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin\/orphanin FQ in alcohol-preferring rats","volume":"172","author":"Ciccocioppo","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0060","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/npp.2014.113","article-title":"Chronic treatment with novel brain-penetrating selective NOP receptor agonist MT-7716 reduces alcohol drinking and seeking in the rat","volume":"39","author":"Ciccocioppo","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2146\/ajhp140157","article-title":"The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems","volume":"71","author":"Cobaugh","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0070","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0091-3057(99)00047-7","article-title":"Drug discrimination in neurobiology","volume":"64","author":"Colpaert","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0075","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.npp.1301479","article-title":"Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers","volume":"33","author":"Comer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00008877-200402000-00008","article-title":"Modulation of the discriminative stimulus effects of mu opioid agonists in rats: I. Effects of dopamine D2\/3 antagonists","volume":"15","author":"Cook","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00008877-200402000-00009","article-title":"Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2\/3 agonists","volume":"15","author":"Cook","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-3057(90)90168-H","article-title":"Selective D1 and D2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin","volume":"35","author":"Corrigall","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0095","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0196-9781(00)00250-3","article-title":"Nociceptin differentially affects morphine-induced dopamine release from the nucleus accumbens and nucleus caudate in rats","volume":"21","author":"Di Giannuario","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(99)00579-0","article-title":"Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats","volume":"272","author":"Di Giannuario","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0105","doi-asserted-by":"crossref","first-page":"E5511","DOI":"10.1073\/pnas.1605295113","article-title":"A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates","volume":"113","author":"Ding","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(00)02669-X","article-title":"Autoradiographic localization of [3H]nociceptin binding sites in the rat brain","volume":"880","author":"Florin","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0115","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vascn.2015.05.003","article-title":"Abuse liability assessment of hydrocodone under current draft regulatory guidelines","volume":"75","author":"Gauvin","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0120","series-title":"A Comprehensive Guide to Toxicology in Nonclinical Drug Development","first-page":"293","article-title":"Current strategies for abuse liability assessment of new chemical entities","author":"Gauvin","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.117.241083","article-title":"ethanol reversal of tolerance to the antinociceptive effects of oxycodone and hydrocodone","volume":"362","author":"Jacob","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/npp.2016.171","article-title":"Genetic deletion of the Nociceptin\/Orphanin FQ receptor in the rat confers resilience to the development of drug addiction","volume":"42","author":"Kallupi","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0135","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/npp.2009.33","article-title":"Behavioral effects of a synthetic agonist selective for nociceptin\/orphanin FQ peptide receptors in monkeys","volume":"34","author":"Ko","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1096-9861(20000724)423:2<319::AID-CNE9>3.0.CO;2-C","article-title":"Autoradiographic localization of (125)I[Tyr(14)]orphanin FQ\/nociceptin and (125)I[Tyr(10)]orphanin FQ\/nociceptin(1-11) binding sites in rat brain","volume":"423","author":"Letchworth","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist","volume":"349","author":"Linz","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130000609","article-title":"Orphanin FQ\/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats","volume":"154","author":"Lutfy","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"year":"2013","series-title":"Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States","author":"Muhuri","key":"10.1016\/j.drugalcdep.2018.02.035_bib0155"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1471-4159.1999.0730179.x","article-title":"Orphanin FQ\/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis","volume":"73","author":"Murphy","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","article-title":"Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats","volume":"75","author":"Murphy","year":"1996","journal-title":"Neurosci"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0170","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0006-8993(99)01425-0","article-title":"Orphanin FQ\/nociceptin blocks acquisition of morphine place preference","volume":"832","author":"Murphy","year":"1999","journal-title":"Brain Res."},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council","key":"10.1016\/j.drugalcdep.2018.02.035_bib0175"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1096-9861(19991004)412:4<563::AID-CNE2>3.0.CO;2-Z","article-title":"Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding","volume":"412","author":"Neal","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1037\/pha0000028","article-title":"Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl\/6 mice","volume":"23","author":"Neelakantan","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0190","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0022-3565(24)35010-4","article-title":"Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations","volume":"290","author":"Platt","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0195","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0022-3565(24)29288-0","article-title":"Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms","volume":"299","author":"Platt","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0200","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s002130050073","article-title":"Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist","volume":"148","author":"Polidori","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0196-9781(00)00243-6","article-title":"The hyperphagic effect of nociceptin\/orphanin FQ in rats","volume":"21","author":"Polidori","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.104.071423","volume":"311","author":"Recker","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0215","doi-asserted-by":"crossref","first-page":"e00247","DOI":"10.1002\/prp2.247","article-title":"Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin\/orphanin FQ and opioid receptor agonist","volume":"4","author":"Rizzi","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0220","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths \u2014 United States: 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2010.07.036","article-title":"Effects of the NOP receptor agonist Ro65-6570 on the acquisition of opiate- and psychostimulant-induced conditioned place preference in rats","volume":"645","author":"Rutten","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0230","first-page":"253","article-title":"Pharmacological blockade or genetic knockout of the NOP receptor potentiates the rewarding effect of morphine in rats","volume":"114","author":"Rutten","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.115.231134","article-title":"Characterization of the discriminative stimulus effects of a NOP receptor agonist Ro 64-6198 in Rhesus Monkeys","volume":"357","author":"Saccone","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fpsyt.2017.00234","article-title":"Cebranopadol, a mixed opioid agonist, reduces cocaine self-administration through nociceptin opioid and mu opioid receptors","volume":"8","author":"Shen","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0245","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuropharm.2005.04.008","article-title":"The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference","volume":"49","author":"Shoblock","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0091-3057(00)00280-X","article-title":"Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism","volume":"66","author":"Stevenson","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2014.10.029","article-title":"Effects of the NOP agonist SCH221510 on producing and attenuating reinforcing effects as measured by drug self-administration in rats","volume":"745","author":"Sukhtankar","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0260","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2017.11.026","article-title":"Mu-opioid peptide (MOP) and nociceptin\/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat","volume":"129","author":"Tzschentke","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2008.05.007","article-title":"The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers","volume":"98","author":"Walsh","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0275","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0091-3057(94)00375-S","article-title":"Supersensitivity to opioid analgesics following chronic opioid antagonist treatment: relationship to receptor selectivity","volume":"51","author":"Yoburn","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0280","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00213-003-1540-9","article-title":"Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers","volume":"170","author":"Zacny","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2018.02.035_bib0285","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1021\/acs.jmedchem.5b01499","article-title":"Nociceptin Opioid Receptor (NOP) as a therapeutic target: progress in translation from preclinical research to clinical utility","volume":"59","author":"Zaveri","year":"2016","journal-title":"J. Med. Chem."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:45:57Z","timestamp":1751564757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618302047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":57,"alternative-id":["S0376871618302047"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.035","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nociceptin\/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL\/6 mice","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}